An evidence-based approach to hormonal contraception and headaches

Contraception

Volumn 80, Issue 5, 2009, Pages 417-421

  Harris, Marissa ^a   Kaneshiro, Bliss ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

Contraception; Headache; Hormones; Migraine; Stroke

Indexed keywords

COPPER INTRAUTERINE DEVICE; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETONOGESTREL; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE;

ARTICLE; CEREBROVASCULAR ACCIDENT; DISEASE CLASSIFICATION; EVIDENCE BASED PRACTICE; HEADACHE; HORMONAL CONTRACEPTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MENSTRUAL MIGRAINE; MIGRAINE; MIGRAINE WITH AURA; SCIENTIFIC LITERATURE; STROKE; TREATMENT CONTRAINDICATION;

ADULT; CONTRACEPTION; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; EVIDENCE-BASED MEDICINE; FEMALE; HEADACHE; HUMANS; MIGRAINE DISORDERS; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 70349770728     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.04.014     Document Type: Article

References (35)

1. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia 24 Suppl 1 (2004) 9-160
2. Rasmussen B.K. Epidemiology of headache. Cephalalgia 21 (2001) 774-777
3. Loder E.W., Buse D.C., and Golub J.R. Headache and combination estrogen-progestin oral contraceptives: integrating evidence, guidelines, and clinical practice. Headache 45 (2005) 224-231
4. Macgregor E.A. Menstrual migraine: a clinical review. J Fam Plann Reprod Health Care 33 (2007) 36-47
5. Bousser M.G., Conard J., Kittner S., et al. Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy. Cephalalgia 20 (2000) 155-156
6. Carolei A., Marini C., and De Matteis G. History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. Lancet 347 (1996) 1503-1506
7. Tzourio C., Tehindrazanarivelo A., Iglesias S., et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 310 (1995) 830-833
8. Tzourio C., Kittner S.J., Bousser M.G., and Alperovitch A. Migraine and stroke in young women. Cephalalgia 20 (2000) 190-199
9. Kurth T., Slomke M.A., Kase C.S., et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurol 64 (2005) 1020-1026
10. Etminan M., Takkouche B., Isorna F.C., and Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 330 (2005) 63
11. Henrich J.B., and Horwitz R.I. A controlled study of ischemic stroke risk in migraine patients. J J Clin Epidemiol 42 (1989) 773-780
12. Marini C., Carolei A., Roberts R.S., et al. Focal cerebral ischemia in young adults: a collaborative case-control study. The National Research Council Study Group. Neuroepidemiol 12 (1993) 70-81
13. Tzourio C., Iglesias S., Hubert J.B., et al. Migraine and risk of ischaemic stroke: a case-control study. BMJ 307 (1993) 289-292
14. Lidegaard O. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease. Brit J Obstet Gynaecol 102 (1995) 153-159
15. Chang C.L., Donaghy M., and Poulter N. Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ 318 (1999) 13-18
16. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 348 (1996) 498-505
17. Oral contraceptives and stroke in young women. Associated risk factors. Jama 231 (1975) 718-722
18. Curtis K.M., Mohllajee A.P., and Peterson H.B. Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: a systematic review. Contraception 73 (2006) 189-194
19. http://www.who.int/reproductive-health/publications/mec/
20. ACOG Practice Bulletin. The use of hormonal contraception in women with coexisting medical conditions. Number 18, July 2000. Int J Gynaecol Obstet 75 (2001) 93-106
21. LaGuardia K.D., Fisher A.C., Bainbridge J.D., LoCoco J.M., and Friedman A.J. Suppression of estrogen-withdrawal headache with extended transdermal contraception. Fertil Steril 83 (2005) 1875-1877
22. Petitti D.B., Sidney S., Quesenberry Jr. C.P., and Bernstein A. Incidence of stroke and myocardial infarction in women of reproductive age. Stroke 28 (1997) 280-283
23. Bousser M.G. International Headache Society (IHS) Task Force on oral contraceptives (OCs) and hormone replacement therapy (HRT) used in migraine sufferers. Cephalalgia 20 (2000) 147 [discussion 145-6]
24. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Contraception 57 (1998) 315-324
25. MacGregor E.A., Frith A., Ellis J., Aspinall L., and Hackshaw A. Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 67 (2006) 2159-2163
26. MacGregor E.A., and Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology 63 (2004) 351-353
27. Macgregor E.A., and Hackshaw A. Prevention of migraine in the pill-free interval of combined oral contraceptives: a double-blind, placebo-controlled pilot study using natural oestrogen supplements. J Fam Plann Reprod Health Care 28 (2002) 27-31
28. Edelman A., Gallo M.F., Nichols M.D., et al. Continuous versus cyclic use of combined oral contraceptives for contraception: systematic Cochrane review of randomized controlled trials. Hum Reprod 21 (2006) 573-578
29. Miller L., and Notter K.M. Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial. Obstet Gynecol 98 (2001) 771-778
30. Cachrimanidou A.C., Hellberg D., Nilsson S., et al. Long-interval treatment regimen with a desogestrel-containing oral contraceptive. Contraception 48 (1993) 205-216
31. MacGregor A. Migraine associated with menstruation. Functional Neurol 15 Suppl 3 (2000) 143-153
32. Crosignani P.G., Vercellini P., Mosconi P., et al. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol 90 (1997) 257-263
33. Sulak P.J., Scow R.D., Preece C., Riggs M.W., and Kuehl T.J. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 95 (2000) 261-266
34. Loder E.W., Buse D.C., and Golub J.R. Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review. Am J Obstet Gynecol 193 (2005) 636-649
35. Larsson-Cohn U., and Lundberg P.O. Headache and treatment with oral contraceptives. Acta Neurologica Scandinavica 46 (1970) 267-278